What is Nor Consult?
Nor Consult operates as a specialized clinical research organization (CRO) and consulting partner, dedicated to guiding life sciences entities through the complex processes of achieving FDA and EMA approvals for drugs, biologics, and medical devices. The company offers a comprehensive suite of services, including strategic consulting and clinical research execution, with a particular focus on high-stakes therapeutic areas such as cardiovascular, neurovascular, orthopedic, and wound management. Leveraging a team of seasoned experts, Nor Consult prioritizes precision, regulatory assurance, and efficient study management to mitigate risks and control costs for its clientele. Their established reputation for excellence solidifies their role as a trusted ally for sponsors, investors, and regulatory bodies globally.
How much funding has Nor Consult raised?
Nor Consult has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Nor Consult
PPP
Public-Private Partnership
What's next for Nor Consult?
With the recent strategic investment, Nor Consult is poised to enhance its service offerings and expand its operational reach. The company's focus on navigating stringent regulatory pathways for novel therapeutics and medical devices suggests a strategic direction towards deepening its expertise in emerging and high-demand therapeutic areas. This capital will likely fuel advancements in their consulting methodologies, bolster clinical trial support capabilities, and potentially facilitate strategic partnerships to broaden their market penetration. The company's trajectory indicates a continued commitment to enabling client success in bringing critical medical innovations to market.
See full Nor Consult company page
